DDInter1044 DDInter875
Levamisole is an antihelminthic drug that was commonly used for the treatment of parasitic, viral, and bacterial infections. It was manufactured by _Janssen_ and first used in 1969 as an agent to treat worm infestations Levamisole was approved by the FDA in 1990 as an adjuvant treatment for colon cancer. Prior to this, levamisole was used as an antirheumatic therapy in the 1970s and 1980s for patients with rheumatoid arthritis. Because of its immunomodulatory effects, this drug has been studied in the treatment of various immune-mediated diseases, with some studies showing positive results. This drug has also been used in combination with other drugs for the treatment of various cancers. [A178117, A178123] Levamisole was withdrawn from the American market in 2000 due to its ability to cause serious adverse effects, including agranul
Human papillomavirus type 11 L1 capsid protein antigen is contained in Gardasil, or a recombinant Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) vaccine for intramuscular injection. It is an immunization for young men and women 9-26 years of age for the prevention of diseases caused by Human Papillomavirus (HPV) types 6, 11, 16 and 18. The vaccine is prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein of HPV Types 6, 11, 16, and 18, which are produced by separate fermentations in recombinant *Saccharomyces cerevisiae* and self-assembled into VLPs.
Levamisole {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Alemtuzumab
Levamisole {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Ustekinumab
Levamisole {u} may lead to a major life threatening interaction when taken with {v} Samarium (153Sm) lexidronam
Levamisole {u} may lead to a major life threatening interaction when taken with {v} Infliximab
Levamisole may cause a moderate interaction that could exacerbate diseases when taken with Alemtuzumab
Levamisole may cause a moderate interaction that could exacerbate diseases when taken with Ustekinumab
Levamisole may lead to a major life threatening interaction when taken with Samarium (153Sm) lexidronam
Levamisole may lead to a major life threatening interaction when taken with Infliximab